Molecular and Circulating Biomarkers in Patients with Glioblastoma
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23137474
Abstract: Glioblastoma is the most aggressive malignant tumor of the central nervous system with a low survival rate. The difficulty of obtaining this tumor material represents a major limitation, making the real-time monitoring of tumor progression… read more here.
Keywords: molecular circulating; circulating biomarkers; patients glioblastoma; biomarkers patients ... See more keywords